| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |